Alpha-Methyldopa Sesquihydrate
CAS No. 41372-08-1
Alpha-Methyldopa Sesquihydrate( MK-351 hydrate | Methyldopa hydrate | Methyldopa Sesquihydrate | L-(-)-α-Methyldopa hydrate )
Catalog No. M20585 CAS No. 41372-08-1
Alpha-Methyldopa Sesquihydrate is a DOPA decarboxylase inhibitor and indirect α2-adrenergic receptor agonist used to treat hypertension. It inhibits the sympathetic nervous system decreases production of dopamine norepinephrine and epinephrine and exhibits NO-dependent sedative activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 27 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAlpha-Methyldopa Sesquihydrate
-
NoteResearch use only, not for human use.
-
Brief DescriptionAlpha-Methyldopa Sesquihydrate is a DOPA decarboxylase inhibitor and indirect α2-adrenergic receptor agonist used to treat hypertension. It inhibits the sympathetic nervous system decreases production of dopamine norepinephrine and epinephrine and exhibits NO-dependent sedative activity.
-
DescriptionAlpha-Methyldopa Sesquihydrate is a DOPA decarboxylase inhibitor and indirect α2-adrenergic receptor agonist used to treat hypertension. It inhibits the sympathetic nervous system decreases production of dopamine norepinephrine and epinephrine and exhibits NO-dependent sedative activity.(In Vivo):Methyldopa hydrate (L-(-)-α-Methyldopa hydrate; 200 mg/kg; i.p.) decreases the hyperglycemic response in the first 2 hr after Dieldrin treatment.
-
In Vitro——
-
In VivoMethyldopa hydrate (L-(-)-α-Methyldopa hydrate; 200 mg/kg; i.p.) decreases the hyperglycemic response in the first 2 hr after Dieldrin treatment. Animal Model:60-day-old male rats Dosage:200 mg/kg Administration: i.p.Result:Decreased the plasma concentration of glucose in Dieldrin-exposed rats by 24% during the 30 min following its administration.
-
SynonymsMK-351 hydrate | Methyldopa hydrate | Methyldopa Sesquihydrate | L-(-)-α-Methyldopa hydrate
-
PathwayGPCR/G Protein
-
TargetDopamine Receptor
-
RecptorDOPA decarboxylase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number41372-08-1
-
Formula Weight238.24
-
Molecular FormulaC10H13NO4·3/2H?O
-
Purity>98% (HPLC)
-
SolubilityDMSO:33.33 mg/mL (139.90 mM)
-
SMILESO.O.O.C[C@](N)(Cc1ccc(O)c(O)c1)C(O)=O.C[C@](N)(Cc1ccc(O)c(O)c1)C(O)=O
-
Chemical Name(S)-2-amino-3-(34-dihydroxyphenyl)-2-methylpropanoic acid sesquihydrate
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Baila M R Cintas J A . [The use of the combination of L-alpha-methyldopa and dichlorothiazide in the treatment of arterial hypertension][J]. El Día Médico 1962 34:2422.
molnova catalog
related products
-
Tiaspirone hydrochlo...
Tiaspirone hydrochloride (BMY-13859 hydrochloride) exhibits antipsychotic activity. Tiaspirone hydrochloride influences the electrophysiological activity of dopaminergic neurons in the substantia nigra zona compacta (A9 DA cells) and ventral tegmental area (A10 DA cells) in the brain of the rat.
-
(+)-PD 128907 hydroc...
(+)-PD 128907 hydrochloride is an agonist of D3 dopamine receptor .
-
BisfluoroModafinil
CRL-40940 is a selective dopaminergic reuptake inhibitor.
Cart
sales@molnova.com